{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T14:41:52Z","timestamp":1794667312585,"version":"4.9.1"},"reference-count":125,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Cancer"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1038\/s41568-025-00888-7","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T11:49:16Z","timestamp":1762948156000},"page":"104-117","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Neutrophil extracellular traps in cancer"],"prefix":"10.1038","volume":"26","author":[{"given":"Muhammad H.","family":"Shahzad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roni F.","family":"Rayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Cools-Lartigue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan D.","family":"Spicer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"key":"888_CR1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20220011","volume":"219","author":"DF Quail","year":"2022","unstructured":"Quail, D. F. et al. Neutrophil phenotypes and functions in cancer: a consensus statement. J. Exp. Med. 219, e20220011 (2022).","journal-title":"J. Exp. Med."},{"key":"888_CR2","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1126\/science.1092385","volume":"303","author":"V Brinkmann","year":"2004","unstructured":"Brinkmann, V. et al. Neutrophil extracellular traps kill bacteria. Science 303, 1532\u20131535 (2004). This article first demonstrates the presence of NETs and their role in killing bacteria.","journal-title":"Science"},{"key":"888_CR3","doi-asserted-by":"publisher","DOI":"10.1172\/JCI67484","author":"J Cools-Lartigue","year":"2013","unstructured":"Cools-Lartigue, J. et al. Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis. J. Clin. Invest. https:\/\/doi.org\/10.1172\/JCI67484 (2013). This study is the first publication to detail the role of NETs in cancer progression and metastasis.","journal-title":"J. Clin. Invest."},{"key":"888_CR4","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1002\/ijc.30635","volume":"140","author":"S Najmeh","year":"2017","unstructured":"Najmeh, S. et al. Neutrophil extracellular traps sequester circulating tumor cells via \u03b21-integrin mediated interactions. Int. J. Cancer 140, 2321\u20132330 (2017). This study demonstrates that the interaction between NETs and circulating tumour cells is dependent on \u03b21 integrin.","journal-title":"Int. J. Cancer"},{"key":"888_CR5","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.128008","volume":"5","author":"RF Rayes","year":"2019","unstructured":"Rayes, R. F. et al. Primary tumors induce neutrophil extracellular traps with targetable metastasis promoting effects. JCI Insight 5, e128008 (2019). This study demonstrates the role that the primary tumour plays in directing the formation of NETs and enabling their metastatic effect.","journal-title":"JCI Insight"},{"key":"888_CR6","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.4049\/jimmunol.1900240","volume":"204","author":"RF Rayes","year":"2020","unstructured":"Rayes, R. F. et al. Neutrophil extracellular trap-associated CEACAM1 as a putative therapeutic target to prevent metastatic progression of colon carcinoma. J. Immunol. 204, 2285\u20132294 (2020).","journal-title":"J. Immunol."},{"key":"888_CR7","doi-asserted-by":"publisher","first-page":"eaao4227","DOI":"10.1126\/science.aao4227","volume":"361","author":"J Albrengues","year":"2018","unstructured":"Albrengues, J. et al. Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice. Science 361, eaao4227 (2018). This article is the first to report a link between NET-mediated pro-tumorigenic effects and the awakening of dormant cancer cells, suggesting that targeting neutrophils and NETs could help mitigate recurrence.","journal-title":"Science"},{"key":"888_CR8","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.ccell.2023.03.008","volume":"41","author":"A Mousset","year":"2023","unstructured":"Mousset, A. et al. Neutrophil extracellular traps formed during chemotherapy confer treatment resistance via TGF-\u03b2 activation. Cancer Cell 41, 757\u2013775.e710 (2023). This article is the first to show that NETs may promote resistance to cancer chemotherapy.","journal-title":"Cancer Cell"},{"key":"888_CR9","doi-asserted-by":"publisher","DOI":"10.1172\/JCI175031","volume":"134","author":"Y Li","year":"2024","unstructured":"Li, Y. et al. Neutrophil extracellular traps induced by chemotherapy inhibit tumor growth in murine models of colorectal cancer. J. Clin. Invest. 134, e175031 (2024). This article demonstrates that some chemotherapy regimens can induce NETs that inhibit tumour growth, demonstrating the dual role that NETs play in cancer progression and the importance of treatment and the disease context in determining such a role.","journal-title":"J. Clin. Invest."},{"key":"888_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23086-z","volume":"12","author":"S Shinde-Jadhav","year":"2021","unstructured":"Shinde-Jadhav, S. et al. Role of neutrophil extracellular traps in radiation resistance of invasive bladder cancer. Nat. Commun. 12, 2776 (2021). This paper is the first to show that NETs promote resistance to radiation therapy in mouse models of bladder cancer.","journal-title":"Nat. Commun."},{"key":"888_CR11","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20190354","volume":"217","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y. et al. Interleukin-17-induced neutrophil extracellular traps mediate resistance to checkpoint blockade in pancreatic cancer. J. Exp. Med 217, e20190354 (2020). This article suggests that therapeutic targeting of NETs may accentuate the benefits of immune checkpoint inhibition in cancer.\u00a0","journal-title":"J. Exp. Med"},{"key":"888_CR12","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.immuni.2020.03.001","volume":"52","author":"\u00c1 Teijeira","year":"2020","unstructured":"Teijeira, \u00c1. et al. CXCR1 and CXCR2 chemokine receptor agonists produced by tumors induce neutrophil extracellular traps that interfere with immune cytotoxicity. Immunity 52, 856\u2013871.e8 (2020). This article shows that CXCR1 and CXCR2 agonists are critical in driving immunotherapy resistance, supporting targeting of CXCR1\/CXCR2 in cancer.","journal-title":"Immunity"},{"key":"888_CR13","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1002\/hep.29914","volume":"68","author":"DJ van der Windt","year":"2018","unstructured":"van der Windt, D. J. et al. Neutrophil extracellular traps promote inflammation and development of hepatocellular carcinoma in nonalcoholic steatohepatitis. Hepatology 68, 1347\u20131360 (2018).","journal-title":"Hepatology"},{"key":"888_CR14","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/s43018-021-00194-9","volume":"2","author":"SAC McDowell","year":"2021","unstructured":"McDowell, S. A. C. et al. Neutrophil oxidative stress mediates obesity-associated vascular dysfunction and metastatic transmigration. Nat. Cancer 2, 545\u2013562 (2021). This article shows the role of obesity, a modifiable risk factor for cancer mortality, in driving neutrophil and NET-mediated vascular dysfunction and cancer progression.","journal-title":"Nat. Cancer"},{"key":"888_CR15","doi-asserted-by":"publisher","unstructured":"Milette, S. et al. 76P Circadian control of neutrophil extracellular trap formation temporally regulates mecircadian controltastatic lung cancer progression. ESMO Open https:\/\/doi.org\/10.1016\/j.esmoop.2023.101886 (2023).","DOI":"10.1016\/j.esmoop.2023.101886"},{"key":"888_CR16","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.ccell.2024.01.013","volume":"42","author":"XY He","year":"2024","unstructured":"He, X. Y. et al. Chronic stress increases metastasis via neutrophil-mediated changes to the microenvironment. Cancer Cell 42, 474\u2013486.e12 (2024). This article illustrates that chronic stress is a modifiable risk factor for NET-mediated cancer\u00a0progression.","journal-title":"Cancer Cell"},{"key":"888_CR17","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.143888","volume":"6","author":"KH Lagisetty","year":"2021","unstructured":"Lagisetty, K. H. et al. Immune determinants of Barrett\u2019s progression to esophageal adenocarcinoma. JCI Insight 6, e143888 (2021).","journal-title":"JCI Insight"},{"key":"888_CR18","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1002\/mc.20870","volume":"51","author":"HG Vikis","year":"2012","unstructured":"Vikis, H. G. et al. Neutrophils are required for 3-methylcholanthrene-initiated, butylated hydroxytoluene-promoted lung carcinogenesis. Mol. Carcinog. 51, 993\u20131002 (2012).","journal-title":"Mol. Carcinog."},{"key":"888_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2020.101277","volume":"23","author":"SK Wculek","year":"2020","unstructured":"Wculek, S. K., Bridgeman, V. L., Peakman, F. & Malanchi, I. Early neutrophil responses to chemical carcinogenesis shape long-term lung cancer susceptibility. iScience 23, 101277 (2020).","journal-title":"iScience"},{"key":"888_CR20","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1093\/mutage\/gep053","volume":"25","author":"N G\u00fcng\u00f6r","year":"2010","unstructured":"G\u00fcng\u00f6r, N. et al. Genotoxic effects of neutrophils and hypochlorous acid. Mutagenesis 25, 149\u2013154 (2010).","journal-title":"Mutagenesis"},{"key":"888_CR21","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1053\/j.gastro.2021.03.027","volume":"161","author":"TM Bui","year":"2021","unstructured":"Bui, T. M. et al. Neutrophils alter DNA repair landscape to impact survival and shape distinct therapeutic phenotypes of colorectal cancer. Gastroenterology 161, 225\u2013238.e15 (2021).","journal-title":"Gastroenterology"},{"key":"888_CR22","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature01322","volume":"420","author":"LM Coussens","year":"2002","unstructured":"Coussens, L. M. & Werb, Z. Inflammation and cancer. Nature 420, 860\u2013867 (2002).","journal-title":"Nature"},{"key":"888_CR23","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.1172\/JCI61067","volume":"122","author":"T Jamieson","year":"2012","unstructured":"Jamieson, T. et al. Inhibition of CXCR2 profoundly suppresses inflammation-driven and spontaneous tumorigenesis. J. Clin. Invest. 122, 3127\u20133144 (2012).","journal-title":"J. Clin. Invest."},{"key":"888_CR24","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1161\/ATVBAHA.117.309897","volume":"38","author":"AK Meher","year":"2018","unstructured":"Meher, A. K. et al. Novel role of IL (interleukin)-1\u03b2 in neutrophil extracellular trap formation and abdominal aortic aneurysms. Arterioscler. Thromb. Vasc. Biol. 38, 843\u2013853 (2018).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"888_CR25","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1016\/S0140-6736(17)32247-X","volume":"390","author":"PM Ridker","year":"2017","unstructured":"Ridker, P. M. et al. Effect of interleukin-1\u03b2 inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial. Lancet 390, 1833\u20131842 (2017).","journal-title":"Lancet"},{"key":"888_CR26","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1200\/JCO.23.00910","volume":"42","author":"EB Garon","year":"2024","unstructured":"Garon, E. B. et al. Canakinumab as adjuvant therapy in patients with completely resected non-small-cell lung cancer: results from the CANOPY-A double-blind, randomized clinical trial. J. Clin. Oncol. 42, 180\u2013191 (2024).","journal-title":"J. Clin. Oncol."},{"key":"888_CR27","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1200\/JCO.23.00980","volume":"42","author":"DSW Tan","year":"2023","unstructured":"Tan, D. S. W. et al. Canakinumab versus placebo in combination with first-line pembrolizumab plus chemotherapy for advanced non\u2013small-cell lung cancer: results from the CANOPY-1 trial. J. Clin. Oncol. 42, 192\u2013204 (2023).","journal-title":"J. Clin. Oncol."},{"key":"888_CR28","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.Cd-21-1252","author":"AK Mattox","year":"2023","unstructured":"Mattox, A. K. et al. The origin of highly elevated cell-free DNA in healthy individuals and patients with pancreatic, colorectal, lung, or ovarian cancer. Cancer Discov. https:\/\/doi.org\/10.1158\/2159-8290.Cd-21-1252 (2023).","journal-title":"Cancer Discov."},{"key":"888_CR29","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41586-023-05874-3","volume":"616","author":"W Hill","year":"2023","unstructured":"Hill, W. et al. Lung adenocarcinoma promotion by air pollutants. Nature 616, 159\u2013167 (2023).","journal-title":"Nature"},{"key":"888_CR30","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2019.1605822","volume":"8","author":"JL Miller-Ocuin","year":"2019","unstructured":"Miller-Ocuin, J. L. et al. DNA released from neutrophil extracellular traps (NETs) activates pancreatic stellate cells and enhances pancreatic tumor growth. Oncoimmunology 8, e1605822 (2019).","journal-title":"Oncoimmunology"},{"key":"888_CR31","doi-asserted-by":"publisher","first-page":"154","DOI":"10.20892\/j.issn.2095-3941.2019.0353","volume":"17","author":"C Zha","year":"2020","unstructured":"Zha, C. et al. Neutrophil extracellular traps mediate the crosstalk between glioma progression and the tumor microenvironment via the HMGB1\/RAGE\/IL-8 axis. Cancer Biol. Med. 17, 154\u2013168 (2020).","journal-title":"Cancer Biol. Med."},{"key":"888_CR32","doi-asserted-by":"publisher","first-page":"5626","DOI":"10.1158\/0008-5472.CAN-19-0800","volume":"79","author":"HO Yazdani","year":"2019","unstructured":"Yazdani, H. O. et al. Neutrophil extracellular traps drive mitochondrial homeostasis in tumors to augment growth. Cancer Res. 79, 5626\u20135639 (2019).","journal-title":"Cancer Res."},{"key":"888_CR33","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1158\/1078-0432.CCR-18-1226","volume":"25","author":"M Nie","year":"2019","unstructured":"Nie, M. et al. Neutrophil extracellular traps induced by IL8 promote diffuse large B-cell lymphoma progression via the TLR9 signaling. Clin. Cancer Res. 25, 1867\u20131879 (2019).","journal-title":"Clin. Cancer Res."},{"key":"888_CR34","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/nm.2084","volume":"16","author":"AM Houghton","year":"2010","unstructured":"Houghton, A. M. et al. Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth. Nat. Med. 16, 219\u2013223 (2010).","journal-title":"Nat. Med."},{"key":"888_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2021.112707","volume":"405","author":"B Zhu","year":"2021","unstructured":"Zhu, B. et al. NF-\u03baB and neutrophil extracellular traps cooperate to promote breast cancer progression and metastasis. Exp. Cell Res. 405, 112707 (2021).","journal-title":"Exp. Cell Res."},{"key":"888_CR36","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.4049\/jimmunol.1900543","volume":"204","author":"L Cristinziano","year":"2020","unstructured":"Cristinziano, L. et al. Anaplastic thyroid cancer cells induce the release of mitochondrial extracellular DNA traps by viable neutrophils. J. Immunol. 204, 1362\u20131372 (2020).","journal-title":"J. Immunol."},{"key":"888_CR37","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s00262-016-1921-7","volume":"66","author":"E Podaza","year":"2017","unstructured":"Podaza, E. et al. Neutrophils from chronic lymphocytic leukemia patients exhibit an increased capacity to release extracellular traps (NETs). Cancer Immunol. Immunother. 66, 77\u201389 (2017).","journal-title":"Cancer Immunol. Immunother."},{"key":"888_CR38","doi-asserted-by":"publisher","DOI":"10.1126\/science.adf6493","volume":"383","author":"MSF Ng","year":"2024","unstructured":"Ng, M. S. F. et al. Deterministic reprogramming of neutrophils within tumors. Science 383, eadf6493 (2024).","journal-title":"Science"},{"key":"888_CR39","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1161\/ATVBAHA.116.307634","volume":"36","author":"L Aldabbous","year":"2016","unstructured":"Aldabbous, L. et al. Neutrophil extracellular traps promote angiogenesis: evidence from vascular pathology in pulmonary hypertension. Arterioscler. Thromb. Vasc. Biol. 36, 2078\u20132087 (2016).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"888_CR40","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/35036374","volume":"2","author":"G Bergers","year":"2000","unstructured":"Bergers, G. et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat. Cell Biol. 2, 737\u2013744 (2000).","journal-title":"Nat. Cell Biol."},{"key":"888_CR41","doi-asserted-by":"publisher","first-page":"20262","DOI":"10.1073\/pnas.0706438104","volume":"104","author":"VC Ardi","year":"2007","unstructured":"Ardi, V. C., Kupriyanova, T. A., Deryugina, E. I. & Quigley, J. P. Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesis. Proc. Natl Acad. Sci. USA 104, 20262\u201320267 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"888_CR42","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.canlet.2009.06.035","volume":"288","author":"TJ Wilson","year":"2010","unstructured":"Wilson, T. J., Nannuru, K. C., Futakuchi, M. & Singh, R. K. Cathepsin G-mediated enhanced TGF-\u03b2 signaling promotes angiogenesis via upregulation of VEGF and MCP-1. Cancer Lett. 288, 162\u2013169 (2010).","journal-title":"Cancer Lett."},{"key":"888_CR43","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1093\/annonc\/mdy004","volume":"29","author":"E Dell\u2019Aquila","year":"2018","unstructured":"Dell\u2019Aquila, E. et al. Prognostic and predictive role of neutrophil\/lymphocytes ratio in metastatic colorectal cancer: a retrospective analysis of the TRIBE study by GONO. Ann. Oncol. 29, 924\u2013930 (2018).","journal-title":"Ann. Oncol."},{"key":"888_CR44","doi-asserted-by":"publisher","first-page":"4157","DOI":"10.3390\/curroncol28050352","volume":"28","author":"Y Eso","year":"2021","unstructured":"Eso, Y. et al. Pretreatment neutrophil-to-lymphocyte ratio as a predictive marker of response to atezolizumab plus bevacizumab for hepatocellular carcinoma. Curr. Oncol. 28, 4157\u20134166 (2021).","journal-title":"Curr. Oncol."},{"key":"888_CR45","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/hepr.13836","volume":"53","author":"H Ochi","year":"2023","unstructured":"Ochi, H. et al. Usefulness of neutrophil-to-lymphocyte ratio in predicting progression and survival outcomes after atezolizumab\u2013bevacizumab treatment for hepatocellular carcinoma. Hepatol. Res. 53, 61\u201371 (2023).","journal-title":"Hepatol. Res."},{"key":"888_CR46","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nm1565","volume":"13","author":"SR Clark","year":"2007","unstructured":"Clark, S. R. et al. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat. Med. 13, 463\u2013469 (2007).","journal-title":"Nat. Med."},{"key":"888_CR47","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nm.1959","volume":"15","author":"K Kessenbrock","year":"2009","unstructured":"Kessenbrock, K. et al. Netting neutrophils in autoimmune small-vessel vasculitis. Nat. Med. 15, 623\u2013625 (2009).","journal-title":"Nat. Med."},{"key":"888_CR48","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/s41586-022-05672-3","volume":"614","author":"M Sorin","year":"2023","unstructured":"Sorin, M. et al. Single-cell spatial landscapes of the lung tumour immune microenvironment. Nature 614, 548\u2013554 (2023). This article shows that neutrophils and other cells interact with other cell types within distinct cellular neighbourhoods, making patients with early-stage NSCLC at risk of disease progression.","journal-title":"Nature"},{"key":"888_CR49","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1158\/2159-8290.CD-23-1380","volume":"14","author":"KSS Enfield","year":"2024","unstructured":"Enfield, K. S. S. et al. Spatial architecture of myeloid and T cells orchestrates immune evasion and clinical outcome in lung cancer. Cancer Discov. 14, 1018\u20131047 (2024).","journal-title":"Cancer Discov."},{"key":"888_CR50","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41572-022-00336-y","volume":"8","author":"AA Khorana","year":"2022","unstructured":"Khorana, A. A. et al. Cancer-associated venous thromboembolism. Nat. Rev. Dis. Prim. 8, 11 (2022).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"888_CR51","doi-asserted-by":"publisher","first-page":"15880","DOI":"10.1073\/pnas.1005743107","volume":"107","author":"TA Fuchs","year":"2010","unstructured":"Fuchs, T. A. et al. Extracellular DNA traps promote thrombosis. Proc. Natl Acad. Sci. USA 107, 15880\u201315885 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"888_CR52","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.3389\/fimmu.2019.02088","volume":"10","author":"T Gomes","year":"2019","unstructured":"Gomes, T. et al. IL-1\u03b2 blockade attenuates thrombosis in a neutrophil extracellular trap-dependent breast cancer model. Front. Immunol. 10, 2088 (2019).","journal-title":"Front. Immunol."},{"key":"888_CR53","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.thromres.2020.01.025","volume":"188","author":"M Yu","year":"2020","unstructured":"Yu, M. et al. Phosphatidylserine-exposing blood cells, microparticles and neutrophil extracellular traps increase procoagulant activity in patients with pancreatic cancer. Thromb. Res. 188, 5\u201316 (2020).","journal-title":"Thromb. Res."},{"key":"888_CR54","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1111\/jth.13951","volume":"16","author":"LM Mauracher","year":"2018","unstructured":"Mauracher, L. M. et al. Citrullinated histone H3, a biomarker of neutrophil extracellular trap formation, predicts the risk of venous thromboembolism in cancer patients. J. Thromb. Haemost. 16, 508\u2013518 (2018).","journal-title":"J. Thromb. Haemost."},{"key":"888_CR55","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/nrc.2017.6","volume":"17","author":"H Peinado","year":"2017","unstructured":"Peinado, H. et al. Pre-metastatic niches: organ-specific homes for metastases. Nat. Rev. Cancer 17, 302\u2013317 (2017).","journal-title":"Nat. Rev. Cancer"},{"key":"888_CR56","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12341","volume":"12","author":"X Su","year":"2023","unstructured":"Su, X. et al. Tumour extracellular vesicles induce neutrophil extracellular traps to promote lymph node metastasis. J. Extracell. Vesicles 12, 12341 (2023). This article demonstrates the importance of NET deposition in forming the pre-metastatic niche and, ultimately, fostering metastatic dissemination in the regional lymph nodes.","journal-title":"J. Extracell. Vesicles"},{"key":"888_CR57","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ccell.2024.12.004","volume":"43","author":"W Lee","year":"2025","unstructured":"Lee, W. et al. Neutrophil extracellular traps promote pre-metastatic niche formation in the omentum by expanding innate-like B cells that express IL-10. Cancer Cell 43, 69\u201385.e11 (2025).","journal-title":"Cancer Cell"},{"key":"888_CR58","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1038\/s41591-024-03075-7","volume":"30","author":"L Bojmar","year":"2024","unstructured":"Bojmar, L. et al. Multi-parametric atlas of the pre-metastatic liver for prediction of metastatic outcome in early-stage pancreatic cancer. Nat. Med. 30, 2170\u20132180 (2024).","journal-title":"Nat. Med."},{"key":"888_CR59","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41586-020-2394-6","volume":"583","author":"L Yang","year":"2020","unstructured":"Yang, L. et al. DNA of neutrophil extracellular traps promotes cancer metastasis via CCDC25. Nature 583, 133\u2013138 (2020).","journal-title":"Nature"},{"key":"888_CR60","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.785222","volume":"12","author":"C Kaltenmeier","year":"2021","unstructured":"Kaltenmeier, C. et al. Neutrophil extracellular traps promote T cell exhaustion in the tumor microenvironment. Front. Immunol. 12, 785222 (2021).","journal-title":"Front. Immunol."},{"key":"888_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2022.101595","volume":"57","author":"ML De Meo","year":"2021","unstructured":"De Meo, M. L. & Spicer, J. D. The role of neutrophil extracellular traps in cancer progression and metastasis. Semin. Immunol. 57, 101595 (2021).","journal-title":"Semin. Immunol."},{"key":"888_CR62","doi-asserted-by":"publisher","first-page":"361ra138","DOI":"10.1126\/scitranslmed.aag1711","volume":"8","author":"J Park","year":"2016","unstructured":"Park, J. et al. Cancer cells induce metastasis-supporting neutrophil extracellular DNA traps. Sci. Transl. Med. 8, 361ra138 (2016).","journal-title":"Sci. Transl. Med."},{"key":"888_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28492-5","volume":"13","author":"X Xia","year":"2022","unstructured":"Xia, X. et al. Neutrophil extracellular traps promote metastasis in gastric cancer patients with postoperative abdominal infectious complications. Nat. Commun. 13, 1017 (2022).","journal-title":"Nat. Commun."},{"key":"888_CR64","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.867516","volume":"13","author":"Y Wang","year":"2022","unstructured":"Wang, Y. et al. Neutrophil extracellular traps (NETs) promote non-small cell lung cancer metastasis by suppressing lncRNA MIR503HG to activate the NF-\u03baB\/NLRP3 inflammasome pathway. Front. Immunol. 13, 867516 (2022).","journal-title":"Front. Immunol."},{"key":"888_CR65","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.3390\/cancers12061542","volume":"12","author":"K Martins-Cardoso","year":"2020","unstructured":"Martins-Cardoso, K. et al. Neutrophil extracellular traps (NETs) promote pro-metastatic phenotype in human breast cancer cells through epithelial\u2013mesenchymal transition. Cancers 12, 1542 (2020).","journal-title":"Cancers"},{"key":"888_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ijmm.2021.4960","volume":"48","author":"T Zhu","year":"2021","unstructured":"Zhu, T. et al. Neutrophil extracellular traps promote gastric cancer metastasis by inducing epithelial\u2013mesenchymal transition. Int. J. Mol. Med. 48, 1\u201313 (2021).","journal-title":"Int. J. Mol. Med."},{"key":"888_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2020.10.015","volume":"497","author":"H Kajioka","year":"2021","unstructured":"Kajioka, H. et al. Targeting neutrophil extracellular traps with thrombomodulin prevents pancreatic cancer metastasis. Cancer Lett. 497, 1\u201313 (2021).","journal-title":"Cancer Lett."},{"key":"888_CR68","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/0749-2081(92)90027-Z","volume":"8","author":"MB Maxwell","year":"1992","unstructured":"Maxwell, M. B. & Maher, K. E. Chemotherapy-induced myelosuppression. Semin. Oncol. Nurs. 8, 113\u2013123 (1992).","journal-title":"Semin. Oncol. Nurs."},{"key":"888_CR69","doi-asserted-by":"publisher","first-page":"271","DOI":"10.2174\/157339406777934717","volume":"2","author":"Y Wang","year":"2006","unstructured":"Wang, Y., Probin, V. & Zhou, D. Cancer therapy-induced residual bone marrow injury\u2014mechanisms of induction and implication for therapy. Curr. Cancer Ther. Rev. 2, 271\u2013279 (2006).","journal-title":"Curr. Cancer Ther. Rev."},{"key":"888_CR70","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1038\/sj.bjc.6605348","volume":"101","author":"Y Kishida","year":"2009","unstructured":"Kishida, Y. et al. Chemotherapy-induced neutropenia as a prognostic factor in advanced non-small-cell lung cancer: results from Japan multinational trial organization LC00-03. Br. J. Cancer 101, 1537\u20131542 (2009).","journal-title":"Br. J. Cancer"},{"key":"888_CR71","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/S1470-2045(05)70255-2","volume":"6","author":"M Di Maio","year":"2005","unstructured":"Di Maio, M. et al. Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of three randomised trials. Lancet Oncol. 6, 669\u2013677 (2005).","journal-title":"Lancet Oncol."},{"key":"888_CR72","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1093\/jleuko\/qiae166","volume":"116","author":"M Bun","year":"2024","unstructured":"Bun, M. et al. G-CSF induces neutrophil extracellular traps formation and promotes ovarian cancer peritoneal dissemination. J. Leukoc. Biol. 116, 1157\u20131168 (2024).","journal-title":"J. Leukoc. Biol."},{"key":"888_CR73","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1016\/j.cell.2023.03.006","volume":"186","author":"P Sharma","year":"2023","unstructured":"Sharma, P. et al. Immune checkpoint therapy\u2014current perspectives and future directions. Cell 186, 1652\u20131669 (2023).","journal-title":"Cell"},{"key":"888_CR74","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1016\/j.immuni.2023.11.002","volume":"56","author":"T Taifour","year":"2023","unstructured":"Taifour, T. et al. The tumor-derived cytokine Chi3l1 induces neutrophil extracellular traps that promote T cell exclusion in triple-negative breast cancer. Immunity 56, 2755\u20132772.e8 (2023).","journal-title":"Immunity"},{"key":"888_CR75","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1016\/j.cell.2023.02.032","volume":"186","author":"J Gungabeesoon","year":"2023","unstructured":"Gungabeesoon, J. et al. A neutrophil response linked to tumor control in immunotherapy. Cell 186, 1448\u20131464.e20 (2023). This manuscript establishes the importance of the neutrophil state as a determinant of cancer progression and cancer therapy efficacy, showing that neutrophils high in Siglec F are tumour-supporting.","journal-title":"Cell"},{"key":"888_CR76","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1016\/j.cell.2023.03.007","volume":"186","author":"D Hirschhorn","year":"2023","unstructured":"Hirschhorn, D. et al. T cell immunotherapies engage neutrophils to eliminate tumor antigen escape variants. Cell 186, 1432\u20131447.e17 (2023).","journal-title":"Cell"},{"key":"888_CR77","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/s41577-022-00787-0","volume":"23","author":"G Wigerblad","year":"2023","unstructured":"Wigerblad, G. & Kaplan, M. J. Neutrophil extracellular traps in systemic autoimmune and autoinflammatory diseases. Nat. Rev. Immunol. 23, 274\u2013288 (2023).","journal-title":"Nat. Rev. Immunol."},{"key":"888_CR78","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1158\/0008-5472.CAN-16-1536","volume":"77","author":"S Tohme","year":"2017","unstructured":"Tohme, S., Simmons, R. L. & Tsung, A. Surgery for cancer: a trigger for metastases. Cancer Res. 77, 1548\u20131552 (2017).","journal-title":"Cancer Res."},{"key":"888_CR79","first-page":"997","volume":"34","author":"LA Liotta","year":"1974","unstructured":"Liotta, L. A., Kleinerman, J. & Saidel, G. M. Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation. Cancer Res. 34, 997\u20131004 (1974).","journal-title":"Cancer Res."},{"key":"888_CR80","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1158\/0008-5472.CAN-15-1591","volume":"76","author":"S Tohme","year":"2016","unstructured":"Tohme, S. et al. Neutrophil extracellular traps promote the development and progression of liver metastases after surgical stress. Cancer Res. 76, 1367\u20131380 (2016).","journal-title":"Cancer Res."},{"key":"888_CR81","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/nri.2017.105","volume":"18","author":"V Papayannopoulos","year":"2018","unstructured":"Papayannopoulos, V. Neutrophil extracellular traps in immunity and disease. Nat. Rev. Immunol. 18, 134\u2013147 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"888_CR82","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19288-6","volume":"11","author":"S Hamarsheh","year":"2020","unstructured":"Hamarsheh, S., Gro\u00df, O., Brummer, T. & Zeiser, R. Immune modulatory effects of oncogenic KRAS in cancer. Nat. Commun. 11, 5439 (2020).","journal-title":"Nat. Commun."},{"key":"888_CR83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12964-020-0517-1","volume":"18","author":"A Shang","year":"2020","unstructured":"Shang, A. et al. Exosomal KRAS mutation promotes the formation of tumor-associated neutrophil extracellular traps and causes deterioration of colorectal cancer by inducing IL-8 expression. Cell Commun. Signal. 18, 1\u201314 (2020).","journal-title":"Cell Commun. Signal."},{"key":"888_CR84","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0160330","volume":"11","author":"M Yoshida","year":"2016","unstructured":"Yoshida, M. et al. Modification of the tumor microenvironment in KRAS or c-MYC-induced ovarian cancer-associated peritonitis. PLoS One 11, e0160330 (2016).","journal-title":"PLoS One"},{"key":"888_CR85","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.lungcan.2018.07.013","volume":"124","author":"I Ferrer","year":"2018","unstructured":"Ferrer, I. et al. KRAS-mutant non-small cell lung cancer: from biology to therapy. Lung Cancer 124, 53\u201364 (2018).","journal-title":"Lung Cancer"},{"key":"888_CR86","doi-asserted-by":"publisher","first-page":"3090","DOI":"10.1038\/s41591-023-02631-x","volume":"29","author":"I Fraterman","year":"2023","unstructured":"Fraterman, I. et al. Association between pretreatment emotional distress and neoadjuvant immune checkpoint blockade response in melanoma. Nat. Med. 29, 3090\u20133099 (2023).","journal-title":"Nat. Med."},{"key":"888_CR87","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1038\/s41591-024-02929-4","volume":"30","author":"Y Zeng","year":"2024","unstructured":"Zeng, Y. et al. Association between pretreatment emotional distress and immune checkpoint inhibitor response in non-small-cell lung cancer. Nat. Med. 30, 1680\u20131688 (2024).","journal-title":"Nat. Med."},{"key":"888_CR88","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1016\/S1470-2045(21)00546-5","volume":"22","author":"DC Qian","year":"2021","unstructured":"Qian, D. C. et al. Effect of immunotherapy time-of-day infusion on overall survival among patients with advanced melanoma in the USA (MEMOIR): a propensity score-matched analysis of a single-centre, longitudinal study. Lancet Oncol. 22, 1777\u20131786 (2021).","journal-title":"Lancet Oncol."},{"key":"888_CR89","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.trecan.2023.11.002","volume":"10","author":"X Zhu","year":"2024","unstructured":"Zhu, X., Maier, G. & Panda, S. Learning from circadian rhythm to transform cancer prevention, prognosis, and survivorship care. Trends Cancer 10, 196\u2013207 (2024).","journal-title":"Trends Cancer"},{"key":"888_CR90","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41590-019-0571-2","volume":"21","author":"JM Adrover","year":"2020","unstructured":"Adrover, J. M. et al. Programmed \u2018disarming\u2019 of the neutrophil proteome reduces the magnitude of inflammation. Nat. Immunol. 21, 135\u2013144 (2020).","journal-title":"Nat. Immunol."},{"key":"888_CR91","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.immuni.2019.01.002","volume":"50","author":"JM Adrover","year":"2019","unstructured":"Adrover, J. M. et al. A neutrophil timer coordinates immune defense and vascular protection. Immunity 50, 390\u2013402.e10 (2019).","journal-title":"Immunity"},{"key":"888_CR92","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1056\/NEJMsr1606602","volume":"375","author":"B Lauby-Secretan","year":"2016","unstructured":"Lauby-Secretan, B. et al. Body fatness and cancer\u2014viewpoint of the IARC Working Group. N. Engl. J. Med. 375, 794\u2013798 (2016).","journal-title":"N. Engl. J. Med."},{"key":"888_CR93","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1056\/NEJMoa021423","volume":"348","author":"EE Calle","year":"2003","unstructured":"Calle, E. E., Rodriguez, C., Walker-Thurmond, K. & Thun, M. J. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N. Engl. J. Med. 348, 1625\u20131638 (2003).","journal-title":"N. Engl. J. Med."},{"key":"888_CR94","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1126\/science.aao5801","volume":"358","author":"OC Olson","year":"2017","unstructured":"Olson, O. C., Quail, D. F. & Joyce, J. A. Obesity and the tumor microenvironment. Science 358, 1130\u20131131 (2017).","journal-title":"Science"},{"key":"888_CR95","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1038\/ncb3578","volume":"19","author":"DF Quail","year":"2017","unstructured":"Quail, D. F. et al. Obesity alters the lung myeloid cell landscape to enhance breast cancer metastasis through IL5 and GM-CSF. Nat. Cell Biol. 19, 974\u2013987 (2017).","journal-title":"Nat. Cell Biol."},{"key":"888_CR96","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.ccell.2016.04.014","volume":"29","author":"CW Steele","year":"2016","unstructured":"Steele, C. W. et al. CXCR2 inhibition profoundly suppresses metastases and augments immunotherapy in pancreatic ductal adenocarcinoma. Cancer Cell 29, 832\u2013845 (2016).","journal-title":"Cancer Cell"},{"key":"888_CR97","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.126853","volume":"4","author":"L Sun","year":"2019","unstructured":"Sun, L. et al. Inhibiting myeloid-derived suppressor cell trafficking enhances T cell immunotherapy. JCI Insight 4, e126853 (2019).","journal-title":"JCI Insight"},{"key":"888_CR98","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1038\/s41586-023-06696-z","volume":"623","author":"C Guo","year":"2023","unstructured":"Guo, C. et al. Targeting myeloid chemotaxis to reverse prostate cancer therapy resistance. Nature 623, 1053\u20131061 (2023).","journal-title":"Nature"},{"key":"888_CR99","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.molmed.2023.09.003","volume":"30","author":"G Lazennec","year":"2024","unstructured":"Lazennec, G., Rajarathnam, K. & Richmond, A. CXCR2 chemokine receptor\u2014a master regulator in cancer and physiology. Trends Mol. Med. 30, 37\u201355 (2024).","journal-title":"Trends Mol. Med."},{"key":"888_CR100","doi-asserted-by":"publisher","first-page":"S745","DOI":"10.1016\/j.annonc.2022.07.583","volume":"33","author":"C Guo","year":"2022","unstructured":"Guo, C. et al. 454O A phase (Ph) I\/II trial of the CXCR2 antagonist AZD5069 in combination with enzalutamide (ENZA) in patients (pts) with metastatic castration resistant prostate cancer (mCRPC). Ann. Oncol. 33, S745 (2022).","journal-title":"Ann. Oncol."},{"key":"888_CR101","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-019-1243-8","volume":"22","author":"LJ Goldstein","year":"2020","unstructured":"Goldstein, L. J. et al. A window-of-opportunity trial of the CXCR1\/2 inhibitor reparixin in operable HER-2-negative breast cancer. Breast Cancer Res. 22, 4 (2020).","journal-title":"Breast Cancer Res."},{"key":"888_CR102","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-019-0706-x","volume":"7","author":"M Bilusic","year":"2019","unstructured":"Bilusic, M. et al. Phase I trial of HuMax-IL8 (BMS-986253), an anti-IL-8 monoclonal antibody, in patients with metastatic or unresectable solid tumors. J. Immunother. Cancer 7, 240 (2019).","journal-title":"J. Immunother. Cancer"},{"key":"888_CR103","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1056\/NEJM199409083311003","volume":"331","author":"HJ Fuchs","year":"1994","unstructured":"Fuchs, H. J. et al. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group. N. Engl. J. Med. 331, 637\u2013642 (1994).","journal-title":"N. Engl. J. Med."},{"key":"888_CR104","doi-asserted-by":"publisher","first-page":"2920","DOI":"10.1002\/1878-0261.12787","volume":"14","author":"Y Xia","year":"2020","unstructured":"Xia, Y. et al. AAV-mediated gene transfer of DNase I in the liver of mice with colorectal cancer reduces liver metastasis and restores local innate and adaptive immune response. Mol. Oncol. 14, 2920\u20132935 (2020).","journal-title":"Mol. Oncol."},{"key":"888_CR105","doi-asserted-by":"publisher","first-page":"5333","DOI":"10.3390\/cancers13215333","volume":"13","author":"H Zhang","year":"2021","unstructured":"Zhang, H. et al. Neutrophils extracellular traps inhibition improves PD-1 blockade immunotherapy in colorectal cancer. Cancers 13, 5333 (2021).","journal-title":"Cancers"},{"key":"888_CR106","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1083\/jcb.201006052","volume":"191","author":"V Papayannopoulos","year":"2010","unstructured":"Papayannopoulos, V., Metzler, K. D., Hakkim, A. & Zychlinsky, A. Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps. J. Cell Biol. 191, 677\u2013691 (2010).","journal-title":"J. Cell Biol."},{"key":"888_CR107","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.3748\/wjg.v21.i12.3720","volume":"21","author":"ZQ Wang","year":"2015","unstructured":"Wang, Z. Q. et al. Effects of neutrophil elastase inhibitor in patients undergoing esophagectomy: a systematic review and meta-analysis. World J. Gastroenterol. 21, 3720\u20133730 (2015).","journal-title":"World J. Gastroenterol."},{"key":"888_CR108","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.2169\/internalmedicine.49.4010","volume":"49","author":"K Iwata","year":"2010","unstructured":"Iwata, K. et al. Effect of neutrophil elastase inhibitor (sivelestat sodium) in the treatment of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): a systematic review and meta-analysis. Intern. Med. 49, 2423\u20132432 (2010).","journal-title":"Intern. Med."},{"key":"888_CR109","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.21037\/tp-22-441","volume":"11","author":"Y Wang","year":"2022","unstructured":"Wang, Y. et al. Sivelestat improves clinical outcomes and decreases ventilator-associated lung injury in children with acute respiratory distress syndrome: a retrospective cohort study. Transl. Pediatr. 11, 1671\u20131681 (2022).","journal-title":"Transl. Pediatr."},{"key":"888_CR110","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.1016\/j.cell.2021.04.016","volume":"184","author":"C Cui","year":"2021","unstructured":"Cui, C. et al. Neutrophil elastase selectively kills cancer cells and attenuates tumorigenesis. Cell 184, 3163\u20133177.e21 (2021).","journal-title":"Cell"},{"key":"888_CR111","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.1158\/0008-5472.CAN-21-4045","volume":"82","author":"H Deng","year":"2022","unstructured":"Deng, H. et al. A novel selective inhibitor JBI-589 targets PAD4-mediated neutrophil migration to suppress tumor progression. Cancer Res. 82, 3561\u20133572 (2022).","journal-title":"Cancer Res."},{"key":"888_CR112","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1158\/1535-7163.MCT-19-1020","volume":"19","author":"M Li","year":"2020","unstructured":"Li, M. et al. A novel peptidylarginine deiminase 4 (PAD4) inhibitor BMS-P5 blocks formation of neutrophil extracellular traps and delays progression of multiple myeloma. Mol. Cancer Ther. 19, 1530\u20131538 (2020).","journal-title":"Mol. Cancer Ther."},{"key":"888_CR113","doi-asserted-by":"publisher","first-page":"6291","DOI":"10.1074\/jbc.M117.775023","volume":"292","author":"A Kulawik","year":"2017","unstructured":"Kulawik, A. et al. IL-1\u03b2-induced and p38(MAPK)-dependent activation of the mitogen-activated protein kinase-activated protein kinase 2 (MK2) in hepatocytes: signal transduction with robust and concentration-independent signal amplification. J. Biol. Chem. 292, 6291\u20136302 (2017).","journal-title":"J. Biol. Chem."},{"key":"888_CR114","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.ccell.2021.04.011","volume":"39","author":"C Garlanda","year":"2021","unstructured":"Garlanda, C. & Mantovani, A. Interleukin-1 in tumor progression, therapy, and prevention. Cancer Cell 39, 1023\u20131027 (2021).","journal-title":"Cancer Cell"},{"key":"888_CR115","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41416-020-01126-7","volume":"124","author":"C Dobie","year":"2021","unstructured":"Dobie, C. & Skropeta, D. Insights into the role of sialylation in cancer progression and metastasis. Br. J. Cancer 124, 76\u201390 (2021).","journal-title":"Br. J. Cancer"},{"key":"888_CR116","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1038\/s41589-020-0622-x","volume":"16","author":"MA Gray","year":"2020","unstructured":"Gray, M. A. et al. Targeted glycan degradation potentiates the anticancer immune response in vivo. Nat. Chem. Biol. 16, 1376\u20131384 (2020).","journal-title":"Nat. Chem. Biol."},{"key":"888_CR117","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.3389\/fimmu.2018.02807","volume":"9","author":"J L\u00fcbbers","year":"2018","unstructured":"L\u00fcbbers, J., Rodr\u00edguez, E. & van Kooyk, Y. Modulation of immune tolerance via siglec\u2013sialic acid interactions. Front. Immunol. 9, 2807 (2018).","journal-title":"Front. Immunol."},{"key":"888_CR118","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108164","volume":"32","author":"C Pfirschke","year":"2020","unstructured":"Pfirschke, C. et al. Tumor-promoting Ly-6G+Siglec Fhigh cells are mature and long-lived neutrophils. Cell Rep. 32, 108164 (2020).","journal-title":"Cell Rep."},{"key":"888_CR119","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1038\/s41385-021-00407-5","volume":"14","author":"L Borkner","year":"2021","unstructured":"Borkner, L., Curham, L. M., Wilk, M. M., Moran, B. & Mills, K. H. G. IL-17 mediates protective immunity against nasal infection with Bordetella pertussis by mobilizing neutrophils, especially Siglec-F+ neutrophils. Mucosal Immunol. 14, 1183\u20131202 (2021).","journal-title":"Mucosal Immunol."},{"key":"888_CR120","doi-asserted-by":"publisher","first-page":"CT034","DOI":"10.1158\/1538-7445.AM2023-CT034","volume":"83","author":"JJ Luke","year":"2023","unstructured":"Luke, J. J. et al. Abstract CT034: GLIMMER-01: initial results from a phase 1 dose escalation trial of a first-in-class bi-sialidase (E-602) in solid tumors. Cancer Res. 83, CT034 (2023).","journal-title":"Cancer Res."},{"key":"888_CR121","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aau7534","volume":"11","author":"A Crawford","year":"2019","unstructured":"Crawford, A. et al. A mucin 16 bispecific T cell-engaging antibody for the treatment of ovarian cancer. Sci. Transl. Med. 11, eaau7534 (2019).","journal-title":"Sci. Transl. Med."},{"key":"888_CR122","doi-asserted-by":"publisher","first-page":"TPS5632","DOI":"10.1200\/JCO.2024.42.16_suppl.TPS5632","volume":"42","author":"E Van Nieuwenhuysen","year":"2024","unstructured":"Van Nieuwenhuysen, E. et al. A phase 1\/2 study of ubamatamab (REGN4018), a MUC16\u00d7CD3 bispecific antibody, administered alone or in combination with cemiplimab (anti-PD-1) in patients with recurrent ovarian cancer or MUC16+ endometrial cancer. J. Clin. Oncol. 42, TPS5632 (2024).","journal-title":"J. Clin. Oncol."},{"key":"888_CR123","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1158\/1541-7786.MCR-19-0018","volume":"18","author":"L Shi","year":"2020","unstructured":"Shi, L. et al. Endogenous PAD4 in breast cancer cells mediates cancer extracellular chromatin network formation and promotes lung metastasis. Mol. Cancer Res. 18, 735\u2013747 (2020).","journal-title":"Mol. Cancer Res."},{"key":"888_CR124","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.68283","volume":"11","author":"DO Tilley","year":"2022","unstructured":"Tilley, D. O. et al. Histone H3 clipping is a novel signature of human neutrophil extracellular traps. eLife 11, e68283 (2022). This manuscript identifies a specific histone H3 clipping event that could serve as a sensitive, specific and reproducibly quantitative signature for the measurement of NETs in human blood and tissue.","journal-title":"eLife"},{"key":"888_CR125","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0329352","volume":"20","author":"M Wargnies","year":"2025","unstructured":"Wargnies, M. et al. Quantification of H3.1-nucleosomes using a chemiluminescent immunoassay: a reliable method for neutrophil extracellular trap detection. PLoS One 20, e0329352 (2025).","journal-title":"PLoS One"}],"container-title":["Nature Reviews Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41568-025-00888-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41568-025-00888-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41568-025-00888-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T13:04:10Z","timestamp":1769778250000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41568-025-00888-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":125,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["888"],"URL":"https:\/\/doi.org\/10.1038\/s41568-025-00888-7","relation":{},"ISSN":["1474-175X","1474-1768"],"issn-type":[{"value":"1474-175X","type":"print"},{"value":"1474-1768","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,12]]},"assertion":[{"value":"13 October 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.D.S. has received speaker fees\/honoraria\/consulting fees from Merck, AstraZeneca, BMS, Roche, Novartis, Amgen, Regeneron, Daiichi-Sankyo, Eisai, PeerView, OncLive and Medscape; and grants from AstraZeneca, BMS, Merck, Roche, CLS Therapeutics and Protalix Biotherapeutics. All other authors have no competing interests to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}